FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Theriogenology / The risk of introduction of equine infectious anemia virus i...
Theriogenology2011; 77(2); 445-458; doi: 10.1016/j.theriogenology.2011.08.019

The risk of introduction of equine infectious anemia virus into USA via cloned horse embryos imported from Canada.

Abstract: Deriving horse oocytes in the USA is hampered by the lack of abattoirs processing horse carcasses which could provide abundant quantities of ovaries from slaughtered mares. Therefore, several cloning industries in the USA are attempting to import cloned horse embryos from Canada. Like any agricultural commodity, cloned embryos pose a risk of introduction of exotic animal diseases into the importing country. Under such circumstances, risk assessment could provide an objective, transparent, and internationally accepted means for evaluating the risk. This quantitative risk assessment (QRA) was initiated to determine the risk of introduction of Equine infectious anemia virus (EIAV) into the USA via cloned horse embryos imported from Canada. In assessing the risk, a structured knowledge base regarding cloning in relation to Equine infectious anemia (EIA) was first developed. Based on the knowledge base, a scenario tree was developed to determine conditions (with mathematical probabilities) that could lead to the introduction and maintenance of EIAV along the cloning pathway. Parameters for the occurrence of the event at each node were estimated using published literature. Using @Risk software and setting Monte Carlo simulation at 50,000 iterations, the probability of importing an EIAV-infected cloned horse embryo was 1.8 × 10(-9) (R = 1.5 × 10(-12) to 2.9 × 10(-8)). Taking into account the current protocol for equine cloning and assuming the yield of 5 to 30 clones per year, the possible number of EIAV-infected cloned horse embryos ranged from 2.0 × 10(-10) to 9.1 × 10(-5) (Mean = 1.4×10(-6)) per year. Consequently, it would take up to 1.5 × 10(7) (R = 1.6 × 10(4) to 5.1 × 10(10)) years for EIAV to be introduced into the USA. Based on the knowledge base and our critical pathway analysis, the biological plausibility of introducing EIAV into USA via cloned horse embryos imported from Canada is extremely low.
Copyright © 2012 Elsevier Inc. All rights reserved.
Get Full Text
Publication Date: 2011-09-29 PubMed ID: 21958631PubMed Central: PMC3250577DOI: 10.1016/j.theriogenology.2011.08.019Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the very low likelihood of introducing the equine infectious anemia virus (EIAV) into the USA via cloned horse embryos imported from Canada.

Objective and Methodology of the Research

  • The goal of the study was to quantify the potential risk of introducing EIAV into the U.S. via the import of cloned horse embryos from Canada.
  • The researchers carried out a quantitative risk assessment, which is a scientifically established way to evaluate the risk of certain events or conditions.
  • They first created a foundation of knowledge about cloning and EIA, and they formulated a scenario tree that outlined conditions that could lead to EIAV introduction and maintenance during the cloning process.
  • The probability of each event in the scenario tree was calculated using data from published literature.
  • Monte Carlo simulation was used to estimate the probability of importing an EIAV-infected cloned horse embryo. The simulation was run 50,000 times to ensure accuracy in the prediction.

Findings of the Research

  • The study found that the probability of importing an EIAV-infected cloned horse embryo is extremely low, nearly 1.8 × 10(-9).
  • Considering the current cloning protocols and assuming a yield of 5 to 30 clones per year, the potential number of EIAV-infected cloned horse embryos ranged from 2.0 × 10(-10) to 9.1 × 10(-5) per year. This indicates an extremely low chance per year of an infected embryo.
  • Based on the analysis, it could take up to 1.5 × 10(7) years for EIAV to be introduced into the US via cloned horse embryos imported from Canada.

Conclusion of the Research

  • The final conclusion of the research found that based on the developed knowledge base and critical pathway analysis, the biological possibility of introducing EIAV into the USA via cloned horse embryos imported from Canada is extremely low.
  • The research provides decision-makers with scientific evidence to make informed decisions regarding the import of cloned horse embryos.

Cite This Article

APA
Asseged BD, Habtemariam T, Tameru B, Nganwa D. (2011). The risk of introduction of equine infectious anemia virus into USA via cloned horse embryos imported from Canada. Theriogenology, 77(2), 445-458. https://doi.org/10.1016/j.theriogenology.2011.08.019

Publication

Theriogenology
ISSN: 1879-3231
NlmUniqueID: 0421510
Country: United States
Language: English
Volume: 77
Issue: 2
Pages: 445-458

Researcher Affiliations

Asseged, B D
  • Tuskegee University, Department of Pathobiology, BIMS/CCEBRA, CVMNAH W-B 114, Tuskegee, Alabama, USA. abogale@mytu.tuskegee.edu
Habtemariam, T
    Tameru, B
      Nganwa, D

        MeSH Terms

        • Animals
        • Canada
        • Cloning, Organism / methods
        • Commerce
        • Embryo, Mammalian / virology
        • Equine Infectious Anemia / prevention & control
        • Equine Infectious Anemia / transmission
        • Female
        • Horses / embryology
        • Infectious Anemia Virus, Equine
        • Monte Carlo Method
        • Nuclear Transfer Techniques / veterinary
        • Oocyte Donation / veterinary
        • Oocytes / virology
        • Risk Assessment
        • United States

        Grant Funding

        • G12 RR003059-23 / NCRR NIH HHS

        References

        This article includes 54 references
        1. Lee JW, Wu SC, Tian XC, Barber M, Hoagland T, Riesen J, Lee KH, Tu CF, Cheng WT, Yang X. Production of cloned pigs by whole-cell intracytoplasmic microinjection.. Biol Reprod 2003 Sep;69(3):995-1001.
          pubmed: 12773418doi: 10.1095/biolreprod.103.015917google scholar: lookup
        2. Wells DN. Animal cloning: problems and prospects.. Rev Sci Tech 2005 Apr;24(1):251-64.
          pubmed: 16110893
        3. Moore K, Thatcher WW. Major advances associated with reproduction in dairy cattle.. J Dairy Sci 2006 Apr;89(4):1254-66.
          pubmed: 16537958doi: 10.3168/jds.s0022-0302(06)72194-4google scholar: lookup
        4. Seamark RF. Review on the Current Status of the Extent and Use of Cloning in Animal Production in Australia and New Zealand. Australia: SA Consulting Pty Ltd; 2003.
        5. Oback B, Wells DN. Donor cell differentiation, reprogramming, and cloning efficiency: elusive or illusive correlation?. Mol Reprod Dev 2007 May;74(5):646-54.
          pubmed: 17039535doi: 10.1002/mrd.20654google scholar: lookup
        6. Stice SL, Rzucidlo SJ. Increasing cloning efficiencies requires a better understanding of developmental abnormalities and gene expression in manipulated embryos.. J Anim Sci 2001;79:285–289.
        7. Berg DK, Li C, Asher G, Wells DN, Oback B. Red deer cloned from antler stem cells and their differentiated progeny.. Biol Reprod 2007 Sep;77(3):384-94.
          pubmed: 17522075doi: 10.1095/biolreprod.106.058172google scholar: lookup
        8. Wani NA, Wernery U, Hassan FA, Wernery R, Skidmore JA. Production of the first cloned camel by somatic cell nuclear transfer.. Biol Reprod 2010 Feb;82(2):373-9.
          pubmed: 19812298doi: 10.1095/biolreprod.109.081083google scholar: lookup
        9. European Food Safety Authority (EFSA). Food safety, animal health and welfare and environmental impact of animals derived from cloning by somatic cell nucleus transfer (SCNT) and their offspring and products obtained from those animals: Scientific Opinion of the Scientific Committee.. The EFSA Journal 2008;767:1–49.
        10. Hinrichs K. Update on equine ICSI and cloning.. Theriogenology 2005 Aug;64(3):535-41.
          pubmed: 15985289doi: 10.1016/j.theriogenology.2005.05.010google scholar: lookup
        11. Lagutina I, Lazzari G, Duchi R, Colleoni S, Ponderato N, Turini P, Crotti G, Galli C. Somatic cell nuclear transfer in horses: effect of oocyte morphology, embryo reconstruction method and donor cell type.. Reproduction 2005 Oct;130(4):559-67.
          pubmed: 16183874doi: 10.1530/rep.1.00772google scholar: lookup
        12. Gregg K, Polejaeva I. Risk of equine infectious anemia virus disease transmission through in vitro embryo production using somatic cell nuclear transfer.. Theriogenology 2009 Aug;72(3):289-99.
          pubmed: 19482352doi: 10.1016/j.theriogenology.2009.03.009google scholar: lookup
        13. World Organization for Animal Health (OIE). Somatic cell nuclear transfer in production livestock and horses. Chapter 4.11.. Terrestrial Animal Health Code 2010.
        14. Galli C, Colleoni S, Duchi R, Lagutina I, Lazzari G. Developmental competence of equine oocytes and embryos obtained by in vitro procedures ranging from in vitro maturation and ICSI to embryo culture, cryopreservation and somatic cell nuclear transfer.. Anim Reprod Sci 2007 Mar;98(1-2):39-55.
          pubmed: 17101246doi: 10.1016/j.anireprosci.2006.10.011google scholar: lookup
        15. Yu P, Habtemariam T, Wilson S, Oryang D, Nganwa D, Obasa M, Robnett V. A risk-assessment model for foot and mouth disease (FMD) virus introduction through deboned beef importation.. Prev Vet Med 1997 Apr;30(1):49-59.
          pubmed: 9234411doi: 10.1016/s0167-5877(96)01085-9google scholar: lookup
        16. Miller L, McElvaine MD, McDowell RM, Ahl AS. Developing a quantitative risk assessment process.. Rev Sci Tech 1993 Dec;12(4):1153-64.
          pubmed: 8312617doi: 10.20506/rst.12.4.737google scholar: lookup
        17. Carpenter TE, McBride MD, Hird DW. Risk analysis of quarantine station performance: a case study of the importation of equine infectious anemia virus-infected horses into California.. J Vet Diagn Invest 1998 Jan;10(1):11-6.
          pubmed: 9526854doi: 10.1177/104063879801000103google scholar: lookup
        18. Morley RS. A model for the assessment of the animal disease risks associated with the importation of animals and animal products.. Rev Sci Tech 1993 Dec;12(4):1055-92.
          pubmed: 8312611doi: 10.20506/rst.12.4.743google scholar: lookup
        19. Sutmoller P, Wrathall AE. A quantitative assessment of the risk of transmission of foot-and-mouth disease, bluetongue and vesicular stomatitis by embryo transfer in cattle.. Prev Vet Med 1997 Sep;32(1-2):111-32.
          pubmed: 9361324doi: 10.1016/s0167-5877(96)01118-xgoogle scholar: lookup
        20. Perry GH. Risk assessment of transmission of bovine viral diarrhea virus (BVDV) in abattoir-derived in vitro produced embryos.. Theriogenology 2007 Jul 1;68(1):38-55.
          pubmed: 17462725doi: 10.1016/j.theriogenology.2007.03.022google scholar: lookup
        21. Lammerding AM, Paoli GM. Quantitative risk assessment: an emerging tool for emerging foodborne pathogens.. Emerg Infect Dis 1997 Oct-Dec;3(4):483-7.
          pmc: PMC2640095pubmed: 9366601doi: 10.3201/eid0304.970411google scholar: lookup
        22. Murray N. Import Risk Analysis: Animal and Animal Products. Wellington: New Zealand Ministry of Agriculture and Forestry; 2002. pp. 8–53.
        23. World Organization for Animal Health (OIE). Equine Infectious Anaemia. Chapter 2.5.4.. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Part II 2005.
        24. Stringfellow DA, Seidel S. Manual of the International Embryo Transfer Society (IETS) 3rd ed.. 1998.
        25. Stringfellow DA, Givens MD. Epidemiologic concerns relative to in vivo and in vitro production of livestock embryos.. Anim Reprod Sci 2000 Jul 2;60-61:629-42.
          pubmed: 10844230doi: 10.1016/s0378-4320(00)00104-4google scholar: lookup
        26. Li X, Morris LH, Allen WR. In vitro development of horse oocytes reconstructed with the nuclei of fetal and adult cells.. Biol Reprod 2002 May;66(5):1288-92.
          pubmed: 11967189doi: 10.1095/biolreprod66.5.1288google scholar: lookup
        27. Galli C, Lagutina I, Duchi R, Colleoni S, Lazzari G. Somatic cell nuclear transfer in horses.. Reprod Domest Anim 2008 Jul;43 Suppl 2:331-7.
          pubmed: 18638143doi: 10.1111/j.1439-0531.2008.01181.xgoogle scholar: lookup
        28. Sutmoller P, Wrathall AE. Quantitative assessment of the risk of disease transmission by bovine embryo transfer. series # 17.. Pan American Foot-and-Mouth Disease Center. Scientific and Technical Monograph 1995.
        29. Habtemariam T, Tameru B, Ahmed A, Ngnawa D, Ayanwale L, Beyene G, Robnett V. The Role of Risk Assessment in Managing Risk.. USDA Agricultural Outlook Forum 2005.
        30. Wright B. Equine Infectious Anemia (Swamp Fever). Fact sheet: Ontario Ministry of Agriculture Food and Rural Affairs 1997.
        31. Canadian Food Inspection Agency (CFIA). Equine infectious anaemia.. 2005.
        32. Nagarajan MM, Simard C. Detection of horses infected naturally with equine infectious anemia virus by nested polymerase chain reaction.. J Virol Methods 2001 May;94(1-2):97-109.
          pubmed: 11337044doi: 10.1016/s0166-0934(01)00283-xgoogle scholar: lookup
        33. Leroux C, Cadoré JL, Montelaro RC. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?. Vet Res 2004 Jul-Aug;35(4):485-512.
          pubmed: 15236678doi: 10.1051/vetres:2004020google scholar: lookup
        34. Oaks JL, McGuire TC, Ulibarri C, Crawford TB. Equine infectious anemia virus is found in tissue macrophages during subclinical infection.. J Virol 1998 Sep;72(9):7263-9.
          pmc: PMC109949pubmed: 9696821doi: 10.1128/jvi.72.9.7263-7269.1998google scholar: lookup
        35. Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells.. Proc Natl Acad Sci U S A 1990 Sep;87(18):7245-9.
          pmc: PMC54720pubmed: 1698293doi: 10.1073/pnas.87.18.7245google scholar: lookup
        36. Sun LQ, Warrilow D, Wang L, Witherington C, Macpherson J, Symonds G. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.. Proc Natl Acad Sci U S A 1994 Oct 11;91(21):9715-9.
          pmc: PMC44887pubmed: 7937878doi: 10.1073/pnas.91.21.9715google scholar: lookup
        37. Bicout DJ, Carvalho R, Chalvet-Monfray K, Sabatier P. Distribution of equine infectious anemia in horses in the north of Minas Gerais State, Brazil.. J Vet Diagn Invest 2006 Sep;18(5):479-82.
          pubmed: 17037619doi: 10.1177/104063870601800511google scholar: lookup
        38. Ali Al Ahmad MZ, Fieni F, Martignat L, Chatagnon G, Baril G, Bouvier F, Chebloune Y. Proviral DNA of caprine arthritis encephalitis virus (CAEV) is detected in cumulus oophorus cells but not in oocytes from naturally infected goats.. Theriogenology 2005 Oct 15;64(7):1656-66.
          pubmed: 15885763doi: 10.1016/j.theriogenology.2005.04.005google scholar: lookup
        39. Baccetti B, Benedetto A, Collodel G, Crisá N, di Caro A, Garbuglia AR, Piomboni P. Failure of HIV-1 to infect human oocytes directly.. J Acquir Immune Defic Syndr 1999 Aug 15;21(5):355-61.
          pubmed: 10458615
        40. Terriou P, Auquier P, Chabert-Orsini V, Chinchole JM, Cravello L, Giorgetti C, Halfon P, Salzmann J, Roulier R. Outcome of ICSI in HIV-1-infected women.. Hum Reprod 2005 Oct;20(10):2838-43.
          pubmed: 15980007doi: 10.1093/humrep/dei119google scholar: lookup
        41. Ali Al Ahmad MZ, Fieni F, Guiguen F, Larrat M, Pellerin JL, Roux C, Chebloune Y. Cultured early goat embryos and cells are susceptible to infection with caprine encephalitis virus.. Virology 2006 Sep 30;353(2):307-15.
          pubmed: 16859728doi: 10.1016/j.virol.2006.06.007google scholar: lookup
        42. Vainas E, Papakostaki D, Christodoulou V, Besenfelder U, Amiridis GS, Kuehholzer B, Samartzi F, Brem G. Exploitation of embryos collected from Maedi-Visna seropositive ewes during eradication programs.. Small Ruminant Research 2006;62:129–134.
        43. Le Tallec B, Ponsart C, Marquant-Le Guienne B, Guérin B. Risks of transmissible diseases in relation to embryo transfer.. Reprod Nutr Dev 2001 Sep-Oct;41(5):439-50.
          pubmed: 11993801doi: 10.1051/rnd:2001143google scholar: lookup
        44. Bielanski A. Disinfection procedures for controlling microorganisms in the semen and embryos of humans and farm animals.. Theriogenology 2007 Jul 1;68(1):1-22.
          pubmed: 17512578doi: 10.1016/j.theriogenology.2007.03.025google scholar: lookup
        45. Bielanski A, Nadin-Davis S, Simard C, Maxwell P, Algire J. Experimental collection and transfer of embryos from bovine immunodeficiency virus (BIV) infected cattle.. Theriogenology 2001 Jan 15;55(2):641-8.
          pubmed: 11233789doi: 10.1016/s0093-691x(01)00432-0google scholar: lookup
        46. Bielanski A, Dubuc C. In vitro fertilization of ova from cows experimentally infected with a non-cytopathic strain of bovine viral diarrhea virus.. Anim Reprod Sci 1995;38:215–221.
        47. Stringfellow DA, Riddell KP, Galik PK, Damiani P, Bishop MD, Wright JC. Quality controls for bovine viral diarrhea virus-free IVF embryos.. Theriogenology 2000 Feb;53(3):827-39.
          pubmed: 10735047doi: 10.1016/s0093-691x(99)00277-0google scholar: lookup
        48. Lamara A, Fieni F, Mselli-Lakhal L, Chatagnon G, Bruyas JF, Tainturier D, Battut I, Fornazero C, Chebloune Y. Early embryonic cells from in vivo-produced goat embryos transmit the caprine arthritis-encephalitis virus (CAEV).. Theriogenology 2002 Oct 1;58(6):1153-63.
          pubmed: 12240918doi: 10.1016/s0093-691x(02)00950-0google scholar: lookup
        49. Ali Al Ahmad MZ, Chebloune Y, Bouzar BA, Baril G, Bouvier F, Chatagnon G, Leboeuf B, Pepin M, Guibert JM, Russo P, Manfredi E, Martin J, Fieni F. Lack of risk of transmission of caprine arthritis-encephalitis virus (CAEV) after an appropriate embryo transfer procedure.. Theriogenology 2008 Mar 1;69(4):408-15.
          pubmed: 18036653doi: 10.1016/j.theriogenology.2007.10.009google scholar: lookup
        50. Lagutina I, Lazzari G, Duchi R, Turini P, Tessaro I, Brunetti D, Colleoni S, Crotti G, Galli C. Comparative aspects of somatic cell nuclear transfer with conventional and zona-free method in cattle, horse, pig and sheep.. Theriogenology 2007 Jan 1;67(1):90-8.
          pubmed: 17081599doi: 10.1016/j.theriogenology.2006.09.011google scholar: lookup
        51. Hinrichs K, Choi YH, Love CC, Chung YG, Varner DD. Production of horse foals via direct injection of roscovitine-treated donor cells and activation by injection of sperm extract.. Reproduction 2006 Jun;131(6):1063-72.
          pubmed: 16735545doi: 10.1530/rep.1.01095google scholar: lookup
        52. Zhang L. Microbiological contamination in mouse gametes and embryos.. 2008.
        53. Wrathall AE. Embryo transfer and disease transmission in livestock: A review of recent research.. Theriogenology 1995;43:81–88.
        54. Thibier M. Identified and unidentified challenges for reproductive biotechnologies regarding infectious diseases in animal and public health.. Theriogenology 2001 Dec 1;56(9):1465-81.
          pubmed: 11768811doi: 10.1016/s0093-691x(01)00647-1google scholar: lookup

        Citations

        This article has been cited 1 times.
        1. Hisey EA, Ross PJ, Meyers S. Genetic Manipulation of the Equine Oocyte and Embryo.. J Equine Vet Sci 2021 Apr;99:103394.
          doi: 10.1016/j.jevs.2021.103394pubmed: 33781418google scholar: lookup
        Subscribe to our newsletter
        Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.